Cointime

Oxford Immunotec

company

About

Oxford Immunotec, a medical diagnostics company, develops tests for various diseases based on its innovative T cell measurement technology.

  • 251 - 500

Highlights

Total Funding Amount
$94M £7M
Funding Rounds
4
Investors
3

Details

Last Funding Type
Series D
Last Funding Money Raised
$26M
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2002
Number Of Employee
251 - 500
Operating Status
Active

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$94M £7M
Oxford Immunotec has raised a total of $94M £7M in funding over 2 rounds. Their latest funding was raised on Jun 18, 2012 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 18, 2012 Series Unknown $28M 2 Invesco — Detail
May 4, 2010 Series D $26M 1 — — Detail
Oct 29, 2007 Series C $40M 1 — — Detail
Aug 10, 2005 Series B £7M 1 Prelude Trust — Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Oxford Immunotec is funded by 3 investors. Invesco and Molten Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Invesco Yes Series Unknown
Molten Ventures — Series Unknown
Prelude Trust — Series C
Cointime
Содержание
компания